107 related articles for article (PubMed ID: 30401380)
1. De Novo Malignancy Following Adult-to-Adult Living Donor Liver Transplantation Focusing on Posttransplantation Lymphoproliferative Disorder.
Mizuno S; Hayasaki A; Ito T; Fujii T; Iizawa Y; Kato H; Murata Y; Tanemura A; Kuriyama N; Azumi Y; Kishiwada M; Usui M; Sakurai H; Isaji S
Transplant Proc; 2018 Nov; 50(9):2699-2704. PubMed ID: 30401380
[TBL] [Abstract][Full Text] [Related]
2. Predictive Factors of De Novo Malignancies After Living-Donor Liver Transplantation: A Single-Center Experience.
Wahab MA; Abdel-Khalek EE; Elshoubary M; Yassen AM; Salah T; Sultan AM; Fathy O; Elmorshedi M; Shiha U; Elsadany M; Adly R; Samy M; Shehta A
Transplant Proc; 2021 Mar; 53(2):636-644. PubMed ID: 33549346
[TBL] [Abstract][Full Text] [Related]
3. De Novo Malignancy After Adult-to-Adult Living Donor Liver Transplantation: A Single-Center Long-Term Experience.
Masuda Y; Mita A; Ohno Y; Kubota K; Notake T; Shimizu A; Soejima Y
Transplant Proc; 2023 May; 55(4):952-955. PubMed ID: 37088616
[TBL] [Abstract][Full Text] [Related]
4. Quality of life and problems affecting recipients more than 10 years after living donor liver transplantation.
Kawagishi N; Takeda I; Miyagi S; Satoh K; Akamatsu Y; Sekiguchi S; Satomi S
Transplant Proc; 2009; 41(1):236-7. PubMed ID: 19249523
[TBL] [Abstract][Full Text] [Related]
5. De Novo Malignancy After Living Donor Liver Transplantation: A Large Volume Experience.
Tiwari A; Saigal S; Choudhary NS; Saha S; Rastogi A; Bhangui P; Saraf N; Srinivasan T; Yadav SK; Gautam D; Nundy S; Soin AS
J Clin Exp Hepatol; 2020; 10(5):448-452. PubMed ID: 33029053
[TBL] [Abstract][Full Text] [Related]
6. Surgical Treatment and Outcome of Patients with
Shoji F; Toyokawa G; Harada N; Itoh S; Harimoto N; Ikegami T; Okamoto T; Soejima Y; Yoshizumi T; Maehara Y
Anticancer Res; 2017 May; 37(5):2619-2623. PubMed ID: 28476836
[TBL] [Abstract][Full Text] [Related]
7. Pretransplant Hepatic Malignancy Increases Risk of De Novo Malignancy after Liver Transplantation.
Park GC; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH; Yoon YI; Cho HD; Kwon JH; Chung YK; Kang SH; Choi JU; Jung IJ; Lee SG
J Korean Med Sci; 2020 Mar; 35(11):e69. PubMed ID: 32193900
[TBL] [Abstract][Full Text] [Related]
8. Surgical resection of pulmonary malignant tumors after living donor liver transplantation.
Shoji F; Kawano D; Ikegami T; Soejima Y; Taketomi A; Yano T; Maehara Y
Ann Thorac Surg; 2009 Jul; 88(1):206-11. PubMed ID: 19559227
[TBL] [Abstract][Full Text] [Related]
9. Post-transplant lymphoproliferative disorder after adult-to-adult living donor liver transplant: case series and review of literature.
Kataoka K; Seo S; Sugawara Y; Ota S; Imai Y; Takahashi T; Fukayama M; Kokudo N; Kurokawa M
Leuk Lymphoma; 2010 Aug; 51(8):1494-501. PubMed ID: 20578817
[TBL] [Abstract][Full Text] [Related]
10. Posttransplant Lymphoproliferative Disorder in Kidney and Liver Transplant Recipients: A Single-Center Experience.
Wójciak M; Gozdowska J; Dęborska-Materkowska D; Perkowska-Ptasińska A; Kosieradzki M; Nazarewski S; Durlik M
Transplant Proc; 2018 Sep; 50(7):2154-2158. PubMed ID: 30177129
[TBL] [Abstract][Full Text] [Related]
11. Defining long-term outcomes with living donor liver transplantation in North America.
Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
[TBL] [Abstract][Full Text] [Related]
12. Malignancies after living-donor and cadaveric lung transplantations in Japanese patients.
Tanaka S; Chen-Yoshikawa TF; Yamada T; Hijiya K; Motoyama H; Aoyama A; Date H
Surg Today; 2016 Dec; 46(12):1415-1419. PubMed ID: 26983711
[TBL] [Abstract][Full Text] [Related]
13. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
Muchtar E; Kramer MR; Vidal L; Ram R; Gurion R; Rosenblat Y; Bakal I; Shpilberg O
Transplantation; 2013 Oct; 96(7):657-63. PubMed ID: 23823652
[TBL] [Abstract][Full Text] [Related]
14. De-novo malignancies after kidney transplantation: A long-term observational study.
Fröhlich FA; Halleck F; Lehner L; Schrezenmeier EV; Naik M; Schmidt D; Khadzhynov D; Kast K; Budde K; Staeck O
PLoS One; 2020; 15(11):e0242805. PubMed ID: 33253202
[TBL] [Abstract][Full Text] [Related]
15. De novo malignancies after adult-to-adult living-donor liver transplantation with a malignancy surveillance program: comparison with a Japanese population-based study.
Kaneko J; Sugawara Y; Tamura S; Aoki T; Sakamoto Y; Hasegawa K; Yamashiki N; Kokudo N
Transplantation; 2013 May; 95(9):1142-7. PubMed ID: 23572128
[TBL] [Abstract][Full Text] [Related]
16. De Novo Malignancies After Liver Transplantation With 14 Cases at a Single Center.
Liu ZN; Wang WT; Yan LN;
Transplant Proc; 2015 Oct; 47(8):2483-7. PubMed ID: 26518956
[TBL] [Abstract][Full Text] [Related]
17. A case of gastric cancer following living donor liver transplantation.
Takehara H; Tanabe K; Fujikuni N; Tahara H; Ide K; Tanaka Y; Yasui W; Ohdan H
Hiroshima J Med Sci; 2014 Sep; 63(1-3):23-6. PubMed ID: 25735064
[TBL] [Abstract][Full Text] [Related]
18. Risks and treatment strategies for de novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.
Dong C; Gao W; Ma N; Sun C; Zheng WP; Wang K; Shen ZY
Pediatr Transplant; 2017 Mar; 21(2):. PubMed ID: 27933716
[TBL] [Abstract][Full Text] [Related]
19. Acute liver failure in children-Is living donor liver transplantation justified?
Szymczak M; Kaliciński P; Kowalewski G; Broniszczak D; Markiewicz-Kijewska M; Ismail H; Stefanowicz M; Kowalski A; Teisseyre J; Jankowska I; Patkowski W
PLoS One; 2018; 13(2):e0193327. PubMed ID: 29474400
[TBL] [Abstract][Full Text] [Related]
20. Treatment and outcomes of extrahepatic malignancy incidentally diagnosed during pretransplant evaluation for living donor liver transplantation.
Park GC; Hwang S; Song GW; Jung DH; Moon DB; Ahn CS; Kim KH; Ha TY; Yoon YI; Lee SG
J Hepatobiliary Pancreat Sci; 2020 Apr; 27(4):200-210. PubMed ID: 31957982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
